Cargando…

Preclinical Investigation of Trifluoperazine as a Novel Therapeutic Agent for the Treatment of Pulmonary Arterial Hypertension

Trifluoperazine (TFP), an antipsychotic drug approved by the Food and Drug Administration, has been show to exhibit anti-cancer effects. Pulmonary arterial hypertension (PAH) is a devastating disease characterized by a progressive obliteration of small pulmonary arteries (PAs) due to exaggerated pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grobs, Yann, Awada, Charifa, Lemay, Sarah-Eve, Romanet, Charlotte, Bourgeois, Alice, Toro, Victoria, Nadeau, Valérie, Shimauchi, Kana, Orcholski, Mark, Breuils-Bonnet, Sandra, Tremblay, Eve, Provencher, Steeve, Paulin, Roxane, Boucherat, Olivier, Bonnet, Sébastien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998101/ https://www.ncbi.nlm.nih.gov/pubmed/33805714 http://dx.doi.org/10.3390/ijms22062919

Ejemplares similares

PARP1-PKM2 Axis Mediates Right Ventricular Failure Associated With Pulmonary Arterial Hypertension
por: Shimauchi, Tsukasa, et al.
Publicado: (2022)

Implication of EZH2 in the Pro-Proliferative and Apoptosis-Resistant Phenotype of Pulmonary Artery Smooth Muscle Cells in PAH: A Transcriptomic and Proteomic Approach
por: Habbout, Karima, et al.
Publicado: (2021)

Fetal Gene Reactivation in Pulmonary Arterial Hypertension: GOOD, BAD, or BOTH?
por: Lemay, Sarah-Eve, et al.
Publicado: (2021)

Dual ET(A)/ET(B) blockade with macitentan improves both vascular remodeling and angiogenesis in pulmonary arterial hypertension
por: Nadeau, Valerie, et al.
Publicado: (2017)

Right Ventricular Dysfunction in Pulmonary Hypertension: Is Resistin a Promising Target?
por: Lemay, Sarah‐Eve, et al.
Publicado: (2023)

HDAC6: A Novel Histone Deacetylase Implicated in Pulmonary Arterial Hypertension
por: Boucherat, Olivier, et al.
Publicado: (2017)

Pim-1: A new biomarker in pulmonary arterial hypertension
por: Renard, Sébastien, et al.
Publicado: (2013)

DNA Damage and Pulmonary Hypertension
por: Ranchoux, Benoît, et al.
Publicado: (2016)

The cancer theory of pulmonary arterial hypertension
por: Boucherat, Olivier, et al.
Publicado: (2017)

Reverse Reaction of Nicotinamide Nucleotide Transhydrogenase Promotes ROS Production and Contributes to Right Ventricular Failure
por: Lemay, Sarah-Eve, et al.
Publicado: (2022)

Critical Role for the Advanced Glycation End‐Products Receptor in Pulmonary Arterial Hypertension Etiology
por: Meloche, Jolyane, et al.
Publicado: (2013)

Neutrophil-Lymphocyte Ratio as an Independent Predictor of Survival in Pulmonary Arterial Hypertension: An Exploratory Study
por: Jutras-Beaudoin, Naomie, et al.
Publicado: (2021)

2251: An estrogen receptor α (ERα)-BMPR2-apelin axis mediates 17β-estradiol’s protective effects on right ventricular function in experimental pulmonary hypertension (PH)
por: Lee Frump, Andrea, et al.
Publicado: (2018)

Signal transduction in the development of pulmonary arterial hypertension
por: Malenfant, Simon, et al.
Publicado: (2013)

Exercise intolerance in pulmonary arterial hypertension: insight into central and peripheral pathophysiological mechanisms
por: Malenfant, Simon, et al.
Publicado: (2021)

Krüppel-like Factor 5 contributes to pulmonary artery smooth muscle proliferation and resistance to apoptosis in human pulmonary arterial hypertension
por: Courboulin, Audrey, et al.
Publicado: (2011)

Trifluoperazine-Induced Angioedema
por: Osman, Mugtaba, et al.
Publicado: (2014)

Involvement of PFKFB3 in Pulmonary Arterial Hypertension Pathogenesis. Is It All about Glycolysis?
por: Bonnet, Sebastien, et al.
Publicado: (2019)

Pseudo-tetanus following trifluoperazine.
por: Shorten, G. D., et al.
Publicado: (1990)

Trifluoperazine-Induced Cholestatic Jaundice
por: Sharifi, Vandad, et al.
Publicado: (2010)

Hypokalemia with Trifluoperazine at Therapeutic Dose
por: Rehman, Sajjadur, et al.
Publicado: (2017)

COVID-19 and the pulmonary vasculature
por: Provencher, Steeve, et al.
Publicado: (2020)

Effect of p53 activation on experimental right ventricular hypertrophy
por: Veeroju, Swathi, et al.
Publicado: (2020)

Combination therapy in pulmonary arterial hypertension: recent accomplishments and future challenges
por: Lajoie, Annie-Christine, et al.
Publicado: (2017)

Inhibition of dengue virus infection by trifluoperazine
por: Piccini, Luana E., et al.
Publicado: (2022)

STAT3 signaling in pulmonary arterial hypertension
por: Paulin, Roxane, et al.
Publicado: (2012)

Reply to Piquereau and Perros and to Pullamsetti and de Jesus Perez
por: Kurakula, Kondababu, et al.
Publicado: (2019)

Role for miR-204 in human pulmonary arterial hypertension
por: Courboulin, Audrey, et al.
Publicado: (2011)

Reply to Ning et al.: More Insights into the Association between RVX-208 and Pulmonary Arterial Hypertension
por: Provencher, Steeve, et al.
Publicado: (2020)

Reply to Chen et al.: BET Signaling: A Novel Therapeutic Target for Pulmonary Hypertension?
por: Provencher, Steeve, et al.
Publicado: (2020)

Dissecting the Anticancer Mechanism of Trifluoperazine on Pancreatic Ductal Adenocarcinoma
por: Huang, Can, et al.
Publicado: (2019)

Revisiting the Role for HIF Stabilizers in Bronchopulmonary Dysplasia
por: Boucherat, Olivier, et al.
Publicado: (2020)

Interpreting risk reduction in clinical trials for pulmonary arterial hypertension
por: Lajoie, Annie C., et al.
Publicado: (2018)

Trifluoperazine, a calmodulin antagonist, inhibits muscle cell fusion
Publicado: (1983)

Trifluoperazine inhibits phagocytosis in a macrophagelike cultured cell line
Publicado: (1981)

Compromised Cerebrovascular Regulation and Cerebral Oxygenation in Pulmonary Arterial Hypertension
por: Malenfant, Simon, et al.
Publicado: (2017)

Alternatives to the Six-Minute Walk Test in Pulmonary Arterial Hypertension
por: Mainguy, Vincent, et al.
Publicado: (2014)

Continuous reduction in cerebral oxygenation during endurance exercise in patients with pulmonary arterial hypertension
por: Malenfant, Simon, et al.
Publicado: (2020)

Simultaneous RP-HPLC Estimation of Trifluoperazine Hydrochloride and Chlordiazepoxide in Tablet Dosage Forms
por: Patel, Sejal K., et al.
Publicado: (2009)

Activity of Trifluoperazine against Replicating, Non-Replicating and Drug Resistant M. tuberculosis
por: Advani, Meeta J., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_r6hc4e32cm42q63m5rttglu624